Interleukin-29 Suppresses Hepatitis A and C Viral Internal Ribosomal Entry Site-Mediated Translation

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Viral immunology

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/vim.2012.0021PMID 23035851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Possible widespread presence of hepatitis A virus subgenotype IIIA in Japan: Recent trend of hepatitis A causing acute liver failure

  2012cited by this paper
• Promotion of viral internal ribosomal entry site-mediated translation under amino acid starvation.

  2012cited by this paper
• Role of interleukin‐28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

  2011cited by this paper
• New therapies for hepatitis C virus infection.

  2011cited by this paper
• Hepatic STAT1-Nuclear Translocation and Interleukin 28B Polymorphisms Predict Treatment Outcomes in Hepatitis C Virus Genotype 1-Infected Patients

  2011influential reference
• Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral Infections

  2010cited by this paper
• Influenza A virus replication is inhibited in IFN-λ2 and IFN-λ3 transfected or stimulated cells.

  2010cited by this paper
• Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha

  2010cited by this paper
• Hepatitis B Virus e Antigen Downregulates Cytokine Production in Human Hepatoma Cell Lines

  2010influential reference
• Internal ribosomal entry‐site activities of clinical isolate‐derived hepatitis A virus and inhibitory effects of amantadine

  2010influential reference
• Analysis of 5′ Nontranslated Region of Hepatitis A Viral RNA Genotype I from South Korea: Comparison with Disease Severities

  2010cited by this paper
• Nucleotide Variability and Translation Efficiency of the 5′ Untranslated Region of Hepatitis A Virus: Update from Clinical Isolates Associated with Mild and Severe Hepatitis

  2010cited by this paper
• Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents.

  2010cited by this paper
• Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

  2010cited by this paper
• New antiviral therapies for chronic hepatitis C

  2010cited by this paper
• Inhibition of Hepatitis B Virus Replication by MyD88 Involves Accelerated Degradation of Pregenomic RNA and Nuclear Retention of Pre-S/S RNAs

  2010cited by this paper
• Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus

  2010cited by this paper
• Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

  2009cited by this paper
• Phylogenetic analysis of hepatitis A virus in sera from patients with hepatitis A of various severities

  2009cited by this paper
• Characterization of anti-idiotypic antibodies mimicking antibody- and receptor-binding sites on hepatitis A virus

  2009cited by this paper
• New therapies for hepatitis C virus infection.

  2009cited by this paper
• Structural and functional diversity of viral IRESes.

  2009cited by this paper
• Temporal analysis of early immune responses in patients with acute hepatitis B virus infection.

  2009cited by this paper
• Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

  2009cited by this paper
• Antiviral effect of interferon lambda against West Nile virus.

  2009cited by this paper
• La autoantigen suppresses IRES-dependent translation of the hepatitis A virus.

  2008cited by this paper
• Type III Interferon (IFN) Induces a Type I IFN-Like Response in a Restricted Subset of Cells through Signaling Pathways Involving both the Jak-STAT Pathway and the Mitogen-Activated Protein Kinases

  2007cited by this paper
• Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes

  2006influential reference
• Hepatitis A virus: From discovery to vaccines

  2006cited by this paper
• Small Interfering RNA Targeted to Hepatitis C Virus 5′ NontranslatedRegion Exerts Potent Antiviral Effect

  2006influential reference
• Interleukin‐29 uses a type 1 interferon‐like program to promote antiviral responses in human hepatocytes

  2006cited by this paper
• Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes.

  2006cited by this paper
• Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.

  2005influential reference
• Internal Ribosome Entry Sites in Cellular mRNAs: Mystery of Their Existence*

  2005cited by this paper
• Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors.

  2005influential reference
• Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosomal entry site.

  2005cited by this paper
• Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication

  2005cited by this paper
• Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

  2005influential reference
• Lambda Interferon Inhibits Hepatitis B and C Virus Replication

  2005cited by this paper
• IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.

  2003cited by this paper
• Inhibition of internal ribosomal entry site–directed translation of HCV by recombinant IFN‐α correlates with a reduced La protein

  2002cited by this paper
• Replication of a hepatitis A virus replicon detected by genetic recombination in vivo.

  2002cited by this paper
• Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.

  2002cited by this paper
• IL-28, IL-29 and their class II cytokine receptor IL-28R

  2002cited by this paper
• Functional Significance of the Interaction of Hepatitis A Virus RNA with Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH): Opposing Effects of GAPDH and Polypyrimidine Tract Binding Protein on Internal Ribosome Entry Site Function

  2000cited by this paper
• The 3′-Untranslated Region of Hepatitis C Virus RNA Enhances Translation from an Internal Ribosomal Entry Site

  1998cited by this paper
• Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells

  1996cited by this paper
• Identification of the hepatitis A virus internal ribosome entry site: in vivo and in vitro analysis of bicistronic RNAs containing the HAV 5' noncoding region.

  1993cited by this paper
• Identification of a trans-acting activity from liver that stimulates hepatitis A virus translation in vitro.

  1993cited by this paper
• Genetic relatedness of hepatitis A virus strains recovered from different geographical regions.

  1992cited by this paper

• Recent advances in hepatitis A virus research and clinical practice guidelines for hepatitis A virus infection in Japan

  2023cites this paper
• Enhancing the Expression and Purification of IL-29: A study of autoinduction and one-step Purification Methods

  2023cites this paper
• Advances and Breakthroughs in IRES-Directed Translation and Replication of Picornaviruses

  2023cites this paper
• Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination

  2023cites this paper
• Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes

  2022cites this paper
• Current Practice in Bicistronic IRES Reporter Use: A Systematic Review

  2021cites this paper
• Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment

  2021cites this paper
• Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites

  2021cites this paper
• Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease

  2020cites this paper
• Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection

  2020cites this paper
• Antiviral activity of zinc sulfate against hepatitis A virus replication

  2019cites this paper
• Sortida del virus de l’hepatitis a dels hepatòcits: implicacions en la selecció d’antivirals

  2018cites this paper
• The role of IL-29 in immunity and cancer

  2016cites this paper
• Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus

  2015cites this paper
• The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells.

  2015cites this paper
• Suppression of La Antigen Exerts Potential Antiviral Effects against Hepatitis A Virus

  2014cites this paper
• Molecular Biology and Inhibitors of Hepatitis A Virus

  2013cites this paper
• [The function and application of the IL28B gene in HCV infection and treatment].

  2013influential citation
• Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation

  2013cites this paper
• Different effects of three interferons L on Toll-like receptor-related gene expression in HepG2 cells.

  2013cites this paper
• Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C

  2013cites this paper